Skip to content
DraconiticResearch
Search Sources API
194,226 studies31 sourcesUpdated 30 min ago
Peer-reviewedCC BY-NCChemical and Pharmaceutical Bulletin

Synthesis, Tautomeric Behavior, and Biological Activity of 6-Unsubstituted 2-Aryl-1,4-dihydropyrimidines and 4-Unsubstituted 2-Aryl-1,6-dihydropyrimidines

Abstract

Dihydropyrimidines (DPs) show a wide range of biological activities for medicinal applications. Among DP derivatives, 2-aryl-DPs have been reported to show remarkable pharmacological properties. In this work, 6-unsubstituted, N-unsubstituted 2-aryl-1,4-DP and its 1,6-DP tautomer were synthesized using a Pd2dba3/(2-furyl)3P-catalyzed, CuCl-mediated 2-arylation and a deprotection reaction. The sequential reactions give twenty types of the 1,4-DP and the 1,6-DP tautomers in high yields. To clarify the effects of substituents on their tautomeric behavior, 1H-NMR analysis of a mixture of the tautomers was performed. The analysis revealed that not only the electronic properties of substituents at the 2-position of 1,6-DP but also the electronic properties of substituents at the 4-position of 1,4-DP affect the stability of 1,4-DP and 1,6-DP. These compounds were also assessed for their antiproliferative effect on a human promyelocytic leukemia cell line, HL-60. Five compounds showed relatively high inhibitory activity, and their IC50 values were 1.7–3.9 μM. The analysis indicates that the 2-aryl group with a para-substituent and the cyclohexyl group are related to the biological activity.

Related

  1. Mycogenic synthesis of copper oxide nanoparticles using response surface methodology and assessment of their biological potential
    Nishi Thalaian, V. Venkateswara Sarma
    Brazilian Journal of MicrobiologyPeer-reviewedLicence not statedFull textMaterials & polymersPMC
  2. Innovative AuAg bimetallic nanoparticle synthesis using food waste materials: its biological applications and photocatalytic degradation potentials
    Gitishree Das, Jayanta Kumar Patra, Han Seung Shin
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textMaterials & polymersCrossref
  3. Benzimidazolone-based serotonin 5-HT1A or 5-HT7R ligands: Synthesis and biological evaluation
    Eduard Badarau, Franck Suzenet, Andrzej Bojarski +2
    Bioorganic and Medicinal Chemistry LettersPeer-reviewedLicence not stated19 citedOrganic chemistryHAL
  4. Design, synthesis, and biological evaluation of novel 4,5-diaryl-1,2,3-thiadiazole derivatives: anticancer activity and molecular docking studies
    Maryam Ghasemi, Sajad Ghadbeigi, Seyed Nasser Ostad +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOrganic chemistryCrossref
  5. Design, synthesis, and biological evaluation of novel triazolopyrimidine–1,2,3-triazole–acetamide hybrids as potent α-glucosidase inhibitors supported by in silico studies
    Fariba Peytam, Mahmood Biglar, Bahareh Bayati +7
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOrganic chemistryCrossref
BibTeX
@article{nishimura2026synthesis,
  title = {{Synthesis, Tautomeric Behavior, and Biological Activity of 6-Unsubstituted 2-Aryl-1,4-dihydropyrimidines and 4-Unsubstituted 2-Aryl-1,6-dihydropyrimidines}},
  author = {Yoshio Nishimura and Keito Taira and Yusuke Yamamoto and Hidetomo Kikuchi and Rie Arai and Yuki Toguchi and Bo Yuan and Katsuyoshi Sunaga},
  journal = {Chemical and Pharmaceutical Bulletin},
  year = {2026},
  month = sep,
  doi = {10.1248/cpb.c26-00391},
  url = {https://www.jstage.jst.go.jp/article/cpb/74/9/74_c26-00391/_article},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Synthesis, Tautomeric Behavior, and Biological Activity of 6-Unsubstituted 2-Aryl-1,4-dihydropyrimidines and 4-Unsubstituted 2-Aryl-1,6-dihydropyrimidines
AU  - Yoshio Nishimura
AU  - Keito Taira
AU  - Yusuke Yamamoto
AU  - Hidetomo Kikuchi
AU  - Rie Arai
AU  - Yuki Toguchi
AU  - Bo Yuan
AU  - Katsuyoshi Sunaga
PY  - 2026
DA  - 2026/09/25
JO  - Chemical and Pharmaceutical Bulletin
DO  - 10.1248/cpb.c26-00391
UR  - https://www.jstage.jst.go.jp/article/cpb/74/9/74_c26-00391/_article
AB  - Dihydropyrimidines (DPs) show a wide range of biological activities for medicinal applications. Among DP derivatives, 2-aryl-DPs have been reported to show remarkable pharmacological properties. In this work, 6-unsubstituted, N-unsubstituted 2-aryl-1,4-DP and its 1,6-DP tautomer were synthesized using a Pd2dba3/(2-furyl)3P-catalyzed, CuCl-mediated 2-arylation and a deprotection reaction. The sequential reactions give twenty types of the 1,4-DP and the 1,6-DP tautomers in high yields. To clarify the effects of substituents on their tautomeric behavior, 1H-NMR analysis of a mixture of the tautomers was performed. The analysis revealed that not only the electronic properties of substituents at the 2-position of 1,6-DP but also the electronic properties of substituents at the 4-position of 1,4-DP affect the stability of 1,4-DP and 1,6-DP. These compounds were also assessed for their antiproliferative effect on a human promyelocytic leukemia cell line, HL-60. Five compounds showed relatively high inhibitory activity, and their IC50 values were 1.7–3.9 μM. The analysis indicates that the 2-aryl group with a para-substituent and the cyclohexyl group are related to the biological activity.
SN  - 1347-5223
SN  - 0009-2363
ER  -